JESSICA THASITIS: Open Payments
NPI 1356601272 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 40 payments from 16 companies in 2025. Trend: 2023 $482 · 2024 $889 · 2025 $1,206
Food & beverage: $1,161Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $394 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $115 |
| Lilly USA, LLC | 4 | $86 |
| Abbott Laboratories | 4 | $78 |
| ABBVIE INC. | 4 | $74 |
| Exact Sciences Corporation | 4 | $63 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| PFIZER INC. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: Wegovy, Ozempic, VOQUEZNA, REPATHA, FREESTYLE LIBRE 3, Cologuard Collection Kit, Auvelity, UBRELVY.
Industry payments across SC — which companies pay providers there.
